Clinical Trial Update: Metformin for the Prevention of Oral Cancer in Patients With Oral Premalignant Lesions [Phase 1]

View source ↗

Summary

Phase 1 study evaluating metformin for prevention of oral cancer in patients with oral premalignant lesions has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erythroplakia
• Leukoplakia
• Oral Cavity Cancer
• Proliferative Verrucous Leukoplakia

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Thomas Jefferson University | Conditions: Erythroplakia, Leukoplakia | Phase 1 | Status: TERMINATED